| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 10/30/268:00 AM | -$0.74 | -$0.90 | -21.6% | ⚠ Check | — | $0 | — | — | |
| Q2 '26 | 8/11/269:30 AM | -$0.70 | -$0.80 | -14.3% | ⚠ Check | — | $0 | — | — | |
| Q1 '26 | 5/13/268:30 AM | -$0.78 | -$0.73 | +6.4% | ⚠ Check | — | $0 | — | — | |
| Q4 '25 | 3/30/268:01 AM | -$1.14 | -$1.63 | -43.0% | ⚠ Check | — | $0 | — | — | |
| Q3 '25 | 11/13/254:00 PM | -$3.68 | -$3.33 | +9.5% | +58% | — | $0 | — | — | |
| Q2 '25 | 8/12/254:05 PM | -$11.60 | -$43.80 | ⚠ Check | ⚠ Check | — | $0 | — | — | |
| Q1 '25 | 5/14/254:03 PM | -$5.00 | -$5.20GAAP | -4.0% | +42% | — | $0 | — | — |
⚠ Potential error in calculation, check manually. The two EPS figures may be on different share counts (a stock split one source has not adjusted for).
GAAP = diluted EPS as filed with the SEC. Other EPS figures are adjusted (non-GAAP), the basis analysts estimate.